Aclarion, Inc. (ACONW) stock

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30

$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Aclarion total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aclarion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACONW.

Revenue growth33.1% · median -21.8%

Gross margin21.8% · median -29.0%

Operating margin-11592.1% · median -28628.9%

Net margin-10978.5% · median -25282.6%

Advertisement
300 × 250